(Q43906269)
Statements
Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089) (English)
Fabrice Barlesi
Arnaud Scherpereel
Achim Rittmeyer
Antonio Pazzola
Neus Ferrer Tur
Joo-Hang Kim
Myung-Ju Ahn
Joachim G J V Aerts
Vera Gorbunova
Elaine K Wong
Pablo Perez-Moreno
Lada Mitchell